Roman Hovorka1, Jeremy Cordingley. 1. Department of Paediatrics, University of Cambridge, Hills Road, Cambridge CB2 2QQ, UK. rh347@cam.ac.uk
Abstract
BACKGROUND: We investigated the influence of parenteral glucose infusion on insulin-driven tight glucose control (4.4-6.1 mmol/liter) in the critically ill by appraising kinetic characteristics of the glucoregulatory system. METHODS: Turnover characteristics of the glucoregulatory system associated with constant 0, 1.2, and 2.4 mg/kg/min parenteral glucose infusion were obtained by literature review and mass-balance calculations. RESULTS: Without parenteral glucose infusion, the achievement of tight glucose control is hampered by long time delays with an anticipated glucose equilibration half-time (T((1/2))) of 185 min. The constant parenteral glucose infusions of 1.2 and 2.4 mg/kg/min reduce T((1/2)) to 80 and 40 min, respectively. This follows on from the accelerated glucose turnover brought about by the insulin-modulated glucose uptake, which increases in response to increasing exogenous insulin required to achieve tight glucose control. However, large variations exist among glucose turnover characteristics in the critically ill. CONCLUSIONS: The constant parenteral glucose infusion greater or equal to 2.4 mg/kg/min is expected to simplify the achievement of tight glucose control by reducing system delays and may facilitate the development of more intuitive, efficacious, and safer insulin-titration guidelines.
BACKGROUND: We investigated the influence of parenteral glucose infusion on insulin-driven tight glucose control (4.4-6.1 mmol/liter) in the critically ill by appraising kinetic characteristics of the glucoregulatory system. METHODS: Turnover characteristics of the glucoregulatory system associated with constant 0, 1.2, and 2.4 mg/kg/min parenteral glucose infusion were obtained by literature review and mass-balance calculations. RESULTS: Without parenteral glucose infusion, the achievement of tight glucose control is hampered by long time delays with an anticipated glucose equilibration half-time (T((1/2))) of 185 min. The constant parenteral glucose infusions of 1.2 and 2.4 mg/kg/min reduce T((1/2)) to 80 and 40 min, respectively. This follows on from the accelerated glucose turnover brought about by the insulin-modulated glucose uptake, which increases in response to increasing exogenous insulin required to achieve tight glucose control. However, large variations exist among glucose turnover characteristics in the critically ill. CONCLUSIONS: The constant parenteral glucose infusion greater or equal to 2.4 mg/kg/min is expected to simplify the achievement of tight glucose control by reducing system delays and may facilitate the development of more intuitive, efficacious, and safer insulin-titration guidelines.
Authors: Christine L Ahrens; Jeffrey F Barletta; Salmaan Kanji; James G Tyburski; Robert F Wilson; James J Janisse; John W Devlin Journal: Crit Care Med Date: 2005-11 Impact factor: 7.598
Authors: S Klein; J Kinney; K Jeejeebhoy; D Alpers; M Hellerstein; M Murray; P Twomey Journal: JPEN J Parenter Enteral Nutr Date: 1997 May-Jun Impact factor: 4.016
Authors: Roman Hovorka; Fariba Shojaee-Moradie; Paul V Carroll; Ludovic J Chassin; Ian J Gowrie; Nicola C Jackson; Romulus S Tudor; A Margot Umpleby; Richard H Jones Journal: Am J Physiol Endocrinol Metab Date: 2002-05 Impact factor: 4.310
Authors: Anthony P Furnary; Guangqiang Gao; Gary L Grunkemeier; YingXing Wu; Kathryn J Zerr; Stephen O Bookin; H Storm Floten; Albert Starr Journal: J Thorac Cardiovasc Surg Date: 2003-05 Impact factor: 5.209
Authors: Salmaan Kanji; Avinder Singh; Michael Tierney; Hilary Meggison; Lauralyn McIntyre; Paul C Hebert Journal: Intensive Care Med Date: 2004-03-20 Impact factor: 17.440
Authors: Philip A Goldberg; Mark D Siegel; Robert S Sherwin; Joshua I Halickman; Michelle Lee; Valerie A Bailey; Sandy L Lee; James D Dziura; Silvio E Inzucchi Journal: Diabetes Care Date: 2004-02 Impact factor: 19.112
Authors: Petr Kopecký; Miloš Mráz; Jan Bláha; Jaroslav Lindner; Stĕpán Svačina; Roman Hovorka; Martin Haluzík Journal: Biomed Res Int Date: 2013-02-20 Impact factor: 3.411